Niue

Niue

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
3.61 (2.92 - 4.23) 2019 Modelled IHME
3.66 (3.01 - 4.27) 2018 Modelled IHME
3.77 (3.09 - 4.49) 2017 Modelled IHME
4.01 (3.28 - 4.69) 2016 Modelled IHME
4.24 (3.38 - 4.95) 2015 Modelled IHME
4.32 (3.52 - 5.01) 2014 Modelled IHME
4.37 (3.59 - 5.08) 2013 Modelled IHME
4.42 (3.62 - 5.13) 2012 Modelled IHME
4.46 (3.68 - 5.19) 2011 Modelled IHME
4.52 (3.72 - 5.32) 2010 Modelled IHME
4.61 (3.79 - 5.41) 2009 Modelled IHME
4.74 (3.83 - 5.54) 2008 Modelled IHME
4.87 (3.87 - 5.70) 2007 Modelled IHME
4.98 (3.93 - 5.82) 2006 Modelled IHME
5.03 (3.96 - 5.90) 2005 Modelled IHME
5.05 (4.02 - 5.89) 2004 Modelled IHME
5.05 (4.07 - 5.90) 2003 Modelled IHME
5.06 (4.11 - 5.89) 2002 Modelled IHME
5.07 (4.15 - 5.91) 2001 Modelled IHME
5.09 (4.18 - 5.98) 2000 Modelled IHME
5.16 (4.28 - 6.06) 1999 Modelled IHME
5.31 (4.42 - 6.30) 1998 Modelled IHME
5.48 (4.53 - 6.60) 1997 Modelled IHME
5.64 (4.63 - 6.85) 1996 Modelled IHME
5.75 (4.62 - 7.10) 1995 Modelled IHME
5.8 (4.71 - 7.06) 1994 Modelled IHME
5.85 (4.76 - 7.03) 1993 Modelled IHME
5.89 (4.80 - 7.04) 1992 Modelled IHME
5.92 (4.82 - 7.05) 1991 Modelled IHME
5.93 (4.83 - 6.99) 1990 Modelled IHME
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.29 (0.20 - 0.40) 2019 Modelled IHME
0.31 (0.20 - 0.42) 2018 Modelled IHME
0.32 (0.20 - 0.44) 2017 Modelled IHME
0.33 (0.22 - 0.44) 2016 Modelled IHME
0.35 (0.23 - 0.47) 2015 Modelled IHME
0.36 (0.24 - 0.48) 2014 Modelled IHME
0.37 (0.25 - 0.50) 2013 Modelled IHME
0.38 (0.25 - 0.52) 2012 Modelled IHME
0.4 (0.25 - 0.54) 2011 Modelled IHME
0.4 (0.26 - 0.56) 2010 Modelled IHME
0.41 (0.26 - 0.56) 2009 Modelled IHME
0.41 (0.27 - 0.57) 2008 Modelled IHME
0.42 (0.27 - 0.57) 2007 Modelled IHME
0.42 (0.27 - 0.58) 2006 Modelled IHME
0.42 (0.27 - 0.58) 2005 Modelled IHME
0.41 (0.27 - 0.58) 2004 Modelled IHME
0.4 (0.26 - 0.56) 2003 Modelled IHME
0.38 (0.25 - 0.53) 2002 Modelled IHME
0.36 (0.25 - 0.51) 2001 Modelled IHME
0.35 (0.24 - 0.50) 2000 Modelled IHME
0.38 (0.26 - 0.53) 1999 Modelled IHME
0.43 (0.29 - 0.60) 1998 Modelled IHME
0.49 (0.33 - 0.69) 1997 Modelled IHME
0.54 (0.36 - 0.76) 1996 Modelled IHME
0.57 (0.37 - 0.79) 1995 Modelled IHME
0.57 (0.38 - 0.78) 1994 Modelled IHME
0.56 (0.37 - 0.78) 1993 Modelled IHME
0.56 (0.37 - 0.77) 1992 Modelled IHME
0.56 (0.36 - 0.76) 1991 Modelled IHME
0.55 (0.35 - 0.75) 1990 Modelled IHME
0 2015 Survey/reported WHO WPRO, Woodring J et al, 2017
0.24 (0.01 - 5.39) 2015 Modelled WHO
Showing out of
Show more
Technical notes

Number of people living with chronic HBV

National
Download
Value Year Type Source
138 (112 - 163) 1990 Modelled IHME
136 (111 - 162) 1991 Modelled IHME
134 (109 - 160) 1992 Modelled IHME
132 (107 - 158) 1993 Modelled IHME
129 (105 - 157) 1994 Modelled IHME
127 (102 - 156) 1995 Modelled IHME
123 (101 - 149) 1996 Modelled IHME
117 (97 - 141) 1997 Modelled IHME
110 (92 - 131) 1998 Modelled IHME
104 (86 - 122) 1999 Modelled IHME
99 (81 - 116) 2000 Modelled IHME
95 (78 - 111) 2001 Modelled IHME
92 (75 - 107) 2002 Modelled IHME
89 (71 - 103) 2003 Modelled IHME
86 (68 - 100) 2004 Modelled IHME
84 (66 - 98) 2005 Modelled IHME
81 (64 - 95) 2006 Modelled IHME
79 (63 - 92) 2007 Modelled IHME
76 (62 - 89) 2008 Modelled IHME
74 (61 - 87) 2009 Modelled IHME
73 (60 - 86) 2010 Modelled IHME
72 (60 - 84) 2011 Modelled IHME
72 (59 - 83) 2012 Modelled IHME
71 (59 - 83) 2013 Modelled IHME
71 (58 - 82) 2014 Modelled IHME
70 (56 - 81) 2015 Modelled IHME
66 (54 - 78) 2016 Modelled IHME
63 (51 - 75) 2017 Modelled IHME
61 (50 - 71) 2018 Modelled IHME
60 (49 - 71) 2019 Modelled IHME
Showing out of
Show more

HBV-related death rate

National
Download
Value (per 100,000) Year Type Source
11.1 (8.07 - 14.50) 2019 Modelled IHME
11 (8.05 - 14.40) 2018 Modelled IHME
11 (8.07 - 14.30) 2017 Modelled IHME
11 (8.06 - 14.20) 2016 Modelled IHME
11 (8.12 - 14.30) 2015 Modelled IHME
11 (8.18 - 14.30) 2014 Modelled IHME
11 (8.12 - 14.40) 2013 Modelled IHME
11 (8.12 - 14.30) 2012 Modelled IHME
11 (8.15 - 14.30) 2011 Modelled IHME
11.1 (8.16 - 14.40) 2010 Modelled IHME
11.2 (8.21 - 14.60) 2009 Modelled IHME
11.4 (8.24 - 14.90) 2008 Modelled IHME
11.5 (8.30 - 15.10) 2007 Modelled IHME
11.6 (8.40 - 15.30) 2006 Modelled IHME
11.6 (8.37 - 15.70) 2005 Modelled IHME
11.7 (8.40 - 15.70) 2004 Modelled IHME
11.6 (8.30 - 15.70) 2003 Modelled IHME
11.5 (8.25 - 15.60) 2002 Modelled IHME
11.5 (8.26 - 15.50) 2001 Modelled IHME
11.4 (8.21 - 15.40) 2000 Modelled IHME
11.7 (8.40 - 15.80) 1999 Modelled IHME
12.4 (8.87 - 16.60) 1998 Modelled IHME
13.1 (9.42 - 17.60) 1997 Modelled IHME
13.7 (9.83 - 18.40) 1996 Modelled IHME
13.8 (10 - 18.60) 1995 Modelled IHME
13.7 (10.10 - 18.20) 1994 Modelled IHME
13.6 (10 - 18.10) 1993 Modelled IHME
13.6 (9.96 - 18) 1992 Modelled IHME
13.4 (9.94 - 17.70) 1991 Modelled IHME
13.3 (9.89 - 17.50) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HBV-related deaths

National
Download
Value Year Type Source
0 (0 - 0) 2019 Modelled IHME
0 (0 - 0) 2018 Modelled IHME
0 (0 - 0) 2017 Modelled IHME
0 (0 - 0) 2016 Modelled IHME
0 (0 - 0) 2015 Modelled IHME
0 (0 - 0) 2014 Modelled IHME
0 (0 - 0) 2013 Modelled IHME
0 (0 - 0) 2012 Modelled IHME
0 (0 - 0) 2011 Modelled IHME
0 (0 - 0) 2010 Modelled IHME
0 (0 - 0) 2009 Modelled IHME
0 (0 - 0) 2008 Modelled IHME
0 (0 - 0) 2007 Modelled IHME
0 (0 - 0) 2006 Modelled IHME
0 (0 - 0) 2005 Modelled IHME
0 (0 - 0) 2004 Modelled IHME
0 (0 - 0) 2003 Modelled IHME
0 (0 - 0) 2002 Modelled IHME
0 (0 - 0) 2001 Modelled IHME
0 (0 - 0) 2000 Modelled IHME
0 (0 - 0) 1999 Modelled IHME
0 (0 - 0) 1998 Modelled IHME
0 (0 - 0) 1997 Modelled IHME
0 (0 - 0) 1996 Modelled IHME
0 (0 - 0) 1995 Modelled IHME
0 (0 - 0) 1994 Modelled IHME
0 (0 - 0) 1993 Modelled IHME
0 (0 - 0) 1992 Modelled IHME
0 (0 - 0) 1991 Modelled IHME
0 (0 - 0) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
48 (39 - 58) 2019 Modelled IHME
48 (38 - 58) 2018 Modelled IHME
48 (39 - 58) 2017 Modelled IHME
48 (39 - 57) 2016 Modelled IHME
47 (38 - 57) 2015 Modelled IHME
47 (38 - 57) 2014 Modelled IHME
47 (38 - 57) 2013 Modelled IHME
47 (38 - 57) 2012 Modelled IHME
47 (38 - 57) 2011 Modelled IHME
47 (38 - 57) 2010 Modelled IHME
47 (38 - 57) 2009 Modelled IHME
47 (38 - 57) 2008 Modelled IHME
47 (38 - 57) 2007 Modelled IHME
47 (38 - 57) 2006 Modelled IHME
47 (38 - 57) 2005 Modelled IHME
47 (38 - 57) 2004 Modelled IHME
47 (39 - 57) 2003 Modelled IHME
47 (39 - 57) 2002 Modelled IHME
48 (39 - 57) 2001 Modelled IHME
48 (39 - 57) 2000 Modelled IHME
48 (39 - 57) 1999 Modelled IHME
49 (40 - 58) 1998 Modelled IHME
49 (41 - 58) 1997 Modelled IHME
50 (41 - 59) 1996 Modelled IHME
50 (41 - 59) 1995 Modelled IHME
50 (41 - 59) 1994 Modelled IHME
50 (41 - 59) 1993 Modelled IHME
49 (41 - 59) 1992 Modelled IHME
49 (40 - 58) 1991 Modelled IHME
49 (40 - 58) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of HepB birth dose

Newborns
Download
Value (%) Year Type Source
54 2018 Survey/reported WHO/UNICEF
84 2017 Survey/reported WHO/UNICEF
88 2016 Survey/reported WHO/UNICEF
92 2015 Survey/reported WHO/UNICEF
96 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
99 2012 Survey/reported WHO/UNICEF
99 2011 Survey/reported WHO/UNICEF
55 2010 Survey/reported WHO/UNICEF
99 2009 Survey/reported WHO/UNICEF
99 2008 Survey/reported WHO/UNICEF
99 2007 Survey/reported WHO/UNICEF
70 2006 Survey/reported WHO/UNICEF
9 2005 Survey/reported WHO/UNICEF
21 2004 Survey/reported WHO/UNICEF
99 2003 Survey/reported WHO/UNICEF
99 2002 Survey/reported WHO/UNICEF
99 2001 Survey/reported WHO/UNICEF
99 2000 Survey/reported WHO/UNICEF
99 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
99 2018 Survey/reported WHO/UNICEF
99 2017 Survey/reported WHO/UNICEF
99 2016 Survey/reported WHO/UNICEF
99 2015 Survey/reported WHO/UNICEF
99 2014 Survey/reported WHO/UNICEF
99 2013 Survey/reported WHO/UNICEF
99 2012 Survey/reported WHO/UNICEF
99 2011 Survey/reported WHO/UNICEF
99 2010 Survey/reported WHO/UNICEF
99 2009 Survey/reported WHO/UNICEF
99 2008 Survey/reported WHO/UNICEF
99 2007 Survey/reported WHO/UNICEF
99 2006 Survey/reported WHO/UNICEF
86 2005 Survey/reported WHO/UNICEF
99 2004 Survey/reported WHO/UNICEF
95 2003 Survey/reported WHO/UNICEF
99 2002 Survey/reported WHO/UNICEF
99 2001 Survey/reported WHO/UNICEF
99 2000 Survey/reported WHO/UNICEF
99 1999 Survey/reported WHO/UNICEF
99 1998 Survey/reported WHO/UNICEF
99 1997 Survey/reported WHO/UNICEF
99 1996 Survey/reported WHO/UNICEF
90 1995 Survey/reported WHO/UNICEF
99 1994 Survey/reported WHO/UNICEF
99 1993 Survey/reported WHO/UNICEF
99 1992 Survey/reported WHO/UNICEF
99 1991 Survey/reported WHO/UNICEF
99 2019 Survey/reported WHO/UNICEF
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
1998
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.59 (0.48 - 0.72) 2019 Modelled IHME
0.58 (0.47 - 0.71) 2018 Modelled IHME
0.58 (0.47 - 0.71) 2017 Modelled IHME
0.58 (0.47 - 0.72) 2016 Modelled IHME
0.59 (0.47 - 0.72) 2015 Modelled IHME
0.59 (0.47 - 0.72) 2014 Modelled IHME
0.59 (0.48 - 0.72) 2013 Modelled IHME
0.59 (0.48 - 0.73) 2012 Modelled IHME
0.6 (0.48 - 0.73) 2011 Modelled IHME
0.6 (0.48 - 0.73) 2010 Modelled IHME
0.6 (0.49 - 0.73) 2009 Modelled IHME
0.6 (0.48 - 0.73) 2008 Modelled IHME
0.6 (0.48 - 0.74) 2007 Modelled IHME
0.6 (0.48 - 0.73) 2006 Modelled IHME
0.6 (0.48 - 0.73) 2005 Modelled IHME
0.6 (0.48 - 0.73) 2004 Modelled IHME
0.6 (0.48 - 0.73) 2003 Modelled IHME
0.6 (0.48 - 0.73) 2002 Modelled IHME
0.6 (0.48 - 0.74) 2001 Modelled IHME
0.6 (0.48 - 0.74) 2000 Modelled IHME
0.6 (0.48 - 0.74) 1999 Modelled IHME
0.6 (0.48 - 0.73) 1998 Modelled IHME
0.6 (0.48 - 0.73) 1997 Modelled IHME
0.59 (0.48 - 0.73) 1996 Modelled IHME
0.59 (0.48 - 0.73) 1995 Modelled IHME
0.59 (0.47 - 0.73) 1994 Modelled IHME
0.59 (0.47 - 0.72) 1993 Modelled IHME
0.59 (0.47 - 0.72) 1992 Modelled IHME
0.58 (0.46 - 0.71) 1991 Modelled IHME
0.58 (0.46 - 0.71) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Number of people living with chronic HCV (RNA+/cAg)

National
Download
Value Year Type Source
13 (11 - 17) 1990 Modelled IHME
13 (11 - 16) 1991 Modelled IHME
13 (11 - 16) 1992 Modelled IHME
13 (11 - 16) 1993 Modelled IHME
13 (11 - 16) 1994 Modelled IHME
13 (11 - 16) 1995 Modelled IHME
13 (10 - 16) 1996 Modelled IHME
13 (10 - 16) 1997 Modelled IHME
12 (10 - 15) 1998 Modelled IHME
12 (10 - 15) 1999 Modelled IHME
12 (9 - 14) 2000 Modelled IHME
11 (9 - 14) 2001 Modelled IHME
11 (9 - 13) 2002 Modelled IHME
11 (8 - 13) 2003 Modelled IHME
10 (8 - 12) 2004 Modelled IHME
10 (8 - 12) 2005 Modelled IHME
10 (8 - 12) 2006 Modelled IHME
10 (8 - 12) 2007 Modelled IHME
10 (8 - 12) 2008 Modelled IHME
10 (8 - 12) 2009 Modelled IHME
10 (8 - 12) 2010 Modelled IHME
10 (8 - 12) 2011 Modelled IHME
10 (8 - 12) 2012 Modelled IHME
10 (8 - 12) 2013 Modelled IHME
10 (8 - 12) 2014 Modelled IHME
10 (8 - 12) 2015 Modelled IHME
10 (8 - 12) 2016 Modelled IHME
10 (8 - 12) 2017 Modelled IHME
10 (8 - 12) 2018 Modelled IHME
10 (8 - 12) 2019 Modelled IHME
Showing out of
Show more

HCV-related death rate

National
Download
Value (per 100,000) Year Type Source
7.61 (5.31 - 10.30) 2019 Modelled IHME
7.62 (5.35 - 10.30) 2018 Modelled IHME
7.62 (5.38 - 10.30) 2017 Modelled IHME
7.65 (5.47 - 10.40) 2016 Modelled IHME
7.7 (5.47 - 10.50) 2015 Modelled IHME
7.76 (5.55 - 10.50) 2014 Modelled IHME
7.82 (5.59 - 10.60) 2013 Modelled IHME
7.87 (5.69 - 10.70) 2012 Modelled IHME
7.94 (5.75 - 10.80) 2011 Modelled IHME
8.02 (5.82 - 10.90) 2010 Modelled IHME
8.1 (5.85 - 11.10) 2009 Modelled IHME
8.19 (5.82 - 11.40) 2008 Modelled IHME
8.2 (5.80 - 11.30) 2007 Modelled IHME
8.21 (5.80 - 11.40) 2006 Modelled IHME
8.2 (5.79 - 11.30) 2005 Modelled IHME
8.24 (5.82 - 11.40) 2004 Modelled IHME
8.26 (5.86 - 11.40) 2003 Modelled IHME
8.26 (5.87 - 11.50) 2002 Modelled IHME
8.26 (5.86 - 11.50) 2001 Modelled IHME
8.27 (5.86 - 11.50) 2000 Modelled IHME
8.15 (5.70 - 11.40) 1999 Modelled IHME
7.87 (5.43 - 11) 1998 Modelled IHME
7.57 (5.15 - 10.80) 1997 Modelled IHME
7.3 (5.04 - 10.30) 1996 Modelled IHME
7.18 (5.05 - 10.10) 1995 Modelled IHME
7.12 (5 - 10.10) 1994 Modelled IHME
7.09 (5.01 - 9.95) 1993 Modelled IHME
7.1 (5.03 - 9.94) 1992 Modelled IHME
7.05 (5.03 - 9.80) 1991 Modelled IHME
7.04 (5 - 9.79) 1990 Modelled IHME
Showing out of
Show more
Technical notes

HCV-related deaths

National
Download
Value Year Type Source
0 (0 - 0) 2019 Modelled IHME
0 (0 - 0) 2018 Modelled IHME
0 (0 - 0) 2017 Modelled IHME
0 (0 - 0) 2016 Modelled IHME
0 (0 - 0) 2015 Modelled IHME
0 (0 - 0) 2014 Modelled IHME
0 (0 - 0) 2013 Modelled IHME
0 (0 - 0) 2012 Modelled IHME
0 (0 - 0) 2011 Modelled IHME
0 (0 - 0) 2010 Modelled IHME
0 (0 - 0) 2009 Modelled IHME
0 (0 - 0) 2008 Modelled IHME
0 (0 - 0) 2007 Modelled IHME
0 (0 - 0) 2006 Modelled IHME
0 (0 - 0) 2005 Modelled IHME
0 (0 - 0) 2004 Modelled IHME
0 (0 - 0) 2003 Modelled IHME
0 (0 - 0) 2002 Modelled IHME
0 (0 - 0) 2001 Modelled IHME
0 (0 - 0) 2000 Modelled IHME
0 (0 - 0) 1999 Modelled IHME
0 (0 - 0) 1998 Modelled IHME
0 (0 - 0) 1997 Modelled IHME
0 (0 - 0) 1996 Modelled IHME
0 (0 - 0) 1995 Modelled IHME
0 (0 - 0) 1994 Modelled IHME
0 (0 - 0) 1993 Modelled IHME
0 (0 - 0) 1992 Modelled IHME
0 (0 - 0) 1991 Modelled IHME
0 (0 - 0) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
23 (16 - 30) 2019 Modelled IHME
23 (16 - 31) 2018 Modelled IHME
23 (16 - 31) 2017 Modelled IHME
23 (16 - 31) 2016 Modelled IHME
23 (16 - 31) 2015 Modelled IHME
23 (16 - 31) 2014 Modelled IHME
24 (16 - 31) 2013 Modelled IHME
24 (17 - 31) 2012 Modelled IHME
24 (16 - 32) 2011 Modelled IHME
24 (17 - 32) 2010 Modelled IHME
24 (17 - 32) 2009 Modelled IHME
24 (17 - 32) 2008 Modelled IHME
24 (17 - 32) 2007 Modelled IHME
24 (17 - 31) 2006 Modelled IHME
24 (16 - 31) 2005 Modelled IHME
24 (16 - 31) 2004 Modelled IHME
24 (16 - 31) 2003 Modelled IHME
24 (16 - 31) 2002 Modelled IHME
24 (17 - 31) 2001 Modelled IHME
24 (17 - 31) 2000 Modelled IHME
24 (17 - 31) 1999 Modelled IHME
24 (17 - 31) 1998 Modelled IHME
24 (17 - 31) 1997 Modelled IHME
24 (17 - 31) 1996 Modelled IHME
24 (17 - 31) 1995 Modelled IHME
24 (17 - 31) 1994 Modelled IHME
24 (17 - 32) 1993 Modelled IHME
25 (18 - 32) 1992 Modelled IHME
25 (18 - 32) 1991 Modelled IHME
25 (18 - 33) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
Yes
Source: WHO
Year of birth dose introduction
1998
Source: WHO
Eligible for HBV generic medicines
Source: MPP
HCV National Action Plan
HCV elimination goal
Eligible for HCV generic medicines
Source: MPP

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
3.61 (%)
2019
(2.92 - 4.23(%))
IHME
HCV (RNA/cAg+)
0.59 (%)
2019
(0.48 - 0.72(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
0
2019
(0 - 0)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
0
2019
(0 - 0)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0 (%)
2015, survey/surveillance
WHO WPRO, Woodring J et al, 2017

Prevalence PWID

No data available

Birth dose vaccination coverage (national)

Survey/surveillance

HBV
99 (%)
2019
WHO/UNICEF

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines

Resources